Home  /  What We Do  /  News

Chris Miller's Article "Achieving Approval for Abuse-Deterrent Opioids in the era of an Opioid Epidemic" Published in The Pharma Letter

We are proud to announce that today The Pharma Letter published an article written by Chris Miller. It’s entitled:Achieving approval for abuse-deterrent opioids in the era of an opioid epidemic. 

 

In this article, Chris provides his perspective on the regulatory challenges pharmaceutical companies face as they try to get abuse-deterrent opioid products approved. In keeping with the 3D mission of providing solutions for problems – Chris offers companies tips on how to address those challenges.

Read the article here.

 

About 3D

 3D Communications is a strategic communications firm that prepares pharmaceutical and device companies for high-stakes regulatory, payer, and other stakeholder interactions. 3D offers a comprehensive and integrated approach to defining, supporting, and articulating value throughout all stages of product development.

Read More